U.S. News

BRIEF-Valeant Pharmaceuticals says Onsolis approved in Canada


May 10 (Reuters) - Valeant Pharmaceuticals International: * Announces regulatory approval of Onsolis(TM) in Canada * Says product will be commercialized by joint venture between Meda AB Valeant Canada ltd * Says product is expected to be available for patients in the third quarter of 2010 ((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)) (For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved.

The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.